Dong Xiao
43Patents
9h-index
142Co-inventors
78Inventor score
Filing activity: Dec 14, 2000 → Oct 12, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7884080B2 | Azetidinone derivatives and methods of use thereof | Human Necessities | 46 | Active |
| US6635630B2 | Selective neurokinin antagonists | Chemistry; Metallurgy | 28 | Expired |
| US7122677B2 | NK1 antagonists | Chemistry; Metallurgy | 22 | Expired |
| US7049320B2 | NK1 antagonists | Chemistry; Metallurgy | 19 | Expired |
| US7902366B2 | NK1 antagonists | Chemistry; Metallurgy | 14 | Expired |
| US7709641B2 | NK1 antagonists | Chemistry; Metallurgy | 14 | Active |
| US6436928B1 | Selective neurokinin antagonists | Chemistry; Metallurgy | 12 | Expired |
| US8273895B2 | NK1 antagonists | Chemistry; Metallurgy | 10 | Active |
| US8796299B2 | NK1 antagonists | Chemistry; Metallurgy | 9 | Active |
| US8026364B2 | NK1 antagonists | Chemistry; Metallurgy | 9 | Active |
| US7041682B2 | NK1 antagonists | Chemistry; Metallurgy | 9 | Expired |
| US8754216B2 | NK1 antagonists | Chemistry; Metallurgy | 8 | Active |
| US7763623B2 | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | Human Necessities | 8 | Active |
| US9957219B2 | Antidiabetic bicyclic compounds | Chemistry; Metallurgy | 5 | Active |
| US8927559B2 | Quinazolinone-type compounds as CRTH2 antagonists | Chemistry; Metallurgy | 4 | Active |
| US6878732B2 | NK1 antagonists | Chemistry; Metallurgy | 3 | Expired |
| US7723342B2 | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | Chemistry; Metallurgy | 3 | Expired |
| US7354922B2 | Bridged ring NK1 antagonists | Human Necessities | 3 | Expired |
| US10138212B2 | Aminoquinazoline compounds as A2A antagonist | Chemistry; Metallurgy | 2 | Active |
| US9469629B2 | NK1 antagonists | Chemistry; Metallurgy | 2 | Active |
| US7737155B2 | Nitrogen-containing heterocyclic compounds and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US7750015B2 | Nitrogen-containing heterocyclic compounds and methods of use thereof | Human Necessities | 2 | Active |
| US10011615B2 | Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties | Chemistry; Metallurgy | 1 | Active |
| US9840512B2 | Antidiabetic bicyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US9469615B2 | Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.